Alan M. Goldberg - Publications

Affiliations: 
Environmental Health Sciences Johns Hopkins University, Baltimore, MD 

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Fritsche E, Grandjean P, Crofton KM, Aschner M, Goldberg A, Heinonen T, Hessel EVS, Hogberg H, Bennekou SH, Lein PJ, Leist M, Mundy WR, Paparella M, Piersma AH, Sachana M, et al. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes. Toxicology and Applied Pharmacology. PMID 29447839 DOI: 10.1016/J.Taap.2018.02.004  0.352
2017 Kerecman Myers D, Goldberg AM, Poth A, Wolf MF, Carraway J, McKim J, Coleman KP, Hutchinson R, Brown R, Krug HF, Bahinski A, Hartung T. From in vivo to in vitro: The medical device testing paradigm shift. Altex. PMID 28539002 DOI: 10.14573/Altex.1608081  0.332
2014 Leist M, Hasiwa N, Rovida C, Daneshian M, Basketter D, Kimber I, Clewell H, Gocht T, Goldberg A, Busquet F, Rossi AM, Schwarz M, Stephens M, Taalman R, Knudsen TB, et al. Consensus report on the future of animal-free systemic toxicity testing. Altex. 31: 341-56. PMID 25061899 DOI: 10.14573/Altex.1406091  0.353
2012 Bal-Price AK, Coecke S, Costa L, Crofton KM, Fritsche E, Goldberg A, Grandjean P, Lein PJ, Li A, Lucchini R, Mundy WR, Padilla S, Persico AM, Seiler AE, Kreysa J. Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. Altex. 29: 202-15. PMID 22892558 DOI: 10.14573/Altex.2012.2.202  0.324
2012 Basketter DA, Clewell H, Kimber I, Rossi A, Blaauboer B, Burrier R, Daneshian M, Eskes C, Goldberg A, Hasiwa N, Hoffmann S, Jaworska J, Knudsen TB, Landsiedel R, Leist M, et al. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report*. Altex. 29: 3-91. PMID 22307314 DOI: 10.14573/Altex.2012.1.003  0.337
2011 Crofton KM, Mundy WR, Lein PJ, Bal-Price A, Coecke S, Seiler AE, Knaut H, Buzanska L, Goldberg A. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. Altex. 28: 9-15. PMID 21311847 DOI: 10.14573/Altex.2011.1.009  0.336
2011 Wilcox N, Goldberg A. Food for thought ... on validation. A puzzle or a mystery: an approach founded on new science. Altex-Alternatives to Animal Experimentation. 28: 3-8. PMID 21311846 DOI: 10.14573/Altex.2011.1.003  0.323
2010 Hartung T, Bruner L, Curren R, Eskes C, Goldberg A, McNamee P, Scott L, Zuang V. First alternative method validated by a retrospective weight-of-evidence approach to replace the Draize eye test for the identification of non-irritant substances for a defined applicability domain. Altex. 27: 43-51. PMID 20390238 DOI: 10.14573/Altex.2010.1.43  0.31
2010 Goldberg AM. The Principles of Humane Experimental Technique: Is It Relevant Today? Altex-Alternatives to Animal Experimentation. 149-151. DOI: 10.14573/Altex.2010.2.149  0.317
2007 Coecke S, Goldberg AM, Allen S, Buzanska L, Calamandrei G, Crofton K, Hareng L, Hartung T, Knaut H, Honegger P, Jacobs M, Lein P, Li A, Mundy W, Owen D, et al. Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environmental Health Perspectives. 115: 924-31. PMID 17589601 DOI: 10.1289/Ehp.9427  0.323
2007 Lein P, Locke P, Goldberg A. Meeting report: alternatives for developmental neurotoxicity testing. Environmental Health Perspectives. 115: 764-8. PMID 17520065 DOI: 10.1289/Ehp.9841  0.347
2006 Becker RA, Borgert CJ, Webb S, Ansell J, Amundson S, Portier CJ, Goldberg A, Bruner LH, Rowan A, Curren RD, Stott WT. Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.S. Regulatory Toxicology and Pharmacology : Rtp. 46: 18-22. PMID 16876299 DOI: 10.1016/J.Yrtph.2006.06.001  0.318
2005 Lein P, Silbergeld E, Locke P, Goldberg AM. In vitro and other alternative approaches to developmental neurotoxicity testing (DNT). Environmental Toxicology and Pharmacology. 19: 735-44. PMID 21783550 DOI: 10.1016/J.Etap.2004.12.035  0.351
2001 Green S, Goldberg A, Zurlo J. TestSmart-high production volume chemicals: an approach to implementing alternatives into regulatory toxicology. Toxicological Sciences : An Official Journal of the Society of Toxicology. 63: 6-14. PMID 11509738 DOI: 10.1093/Toxsci/63.1.6  0.328
1999 Spielmann H, Goldberg AM. In Vitro Methods Toxicology. 1131-1138. DOI: 10.1016/B978-012473270-4/50108-5  0.32
1998 Curren R, Bruner L, Goldberg A, Walum E. 13th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): Validation and acute toxicity testing Environmental Health Perspectives. 106: 419-425. PMID 9599688 DOI: 10.1289/Ehp.98106419  0.304
1996 Goldberg AM, Zurlo J, Rudacille D. The three Rs and biomedical research. Science (New York, N.Y.). 272: 1403. PMID 8633221 DOI: 10.1126/Science.272.5267.1403  0.333
1993 Goldberg AM, Frazier JM, Brusick D, Dickens MS, Flint O, Gettings SD, Hill RN, Lipnick RL, Renskers KJ, Bradlaw JA. Framework for validation and implementation of in vitro toxicity tests. In Vitro Cellular & Developmental Biology. Animal. 29: 688-92. PMID 8407711 DOI: 10.1007/Bf02631424  0.357
1993 Goldberg AM, Frazier JM, Brusick D, Dickens MS, Flint O, Gettings SD, Hill RN, Lipnick RL, Renskers KJ, Bradlaw JA. Report of the Validation and Technology Transfer Committee of the Johns Hopkins Center for Alternatives to Animal Testing. Framework for validation and implementation of in vitro toxicity tests. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 23: 563-72. PMID 8342302 DOI: 10.3109/00498259309059395  0.355
1990 Frazier JM, Goldberg AM. Alternatives to and Reduction of Animal Use in Biomedical Research, Education and Testing Alternatives to Laboratory Animals. 18: 65-74. DOI: 10.1177/026119299001800110.1  0.326
1989 Goldberg AM, Frazier JM. Alternatives to animals in toxicity testing. Scientific American. 261: 24-30. PMID 2667132 DOI: 10.1038/Scientificamerican0889-24  0.33
1987 Goldberg AM, Rowan AN. Conceptual Approaches to Alternate Methods in Toxicological Testing Defence Science Journal. 37: 99-112. DOI: 10.14429/Dsj.37.5896  0.346
1985 Goldberg AM. An approach to the development of in vitro toxicological methods. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 23: 205-8. PMID 4040067 DOI: 10.1016/0278-6915(85)90018-3  0.339
1985 Rowan AN, Goldberg AM. Perspectives on alternatives to current animal testing techniques in preclinical toxicology. Annual Review of Pharmacology and Toxicology. 25: 225-47. PMID 3890703 DOI: 10.1146/Annurev.Pa.25.040185.001301  0.325
1984 Goldberg AM. The Johns Hopkins Center for Alternatives to Animal Testing. Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology. 4: 517-8. PMID 6479496 DOI: 10.1016/0272-0590(84)90040-X  0.339
1983 Goldberg AM. The Johns Hopkins Center for Alternatives to Animal Testing: Highlights of the Center's Activities in 1983 Alternatives to Laboratory Animals. 11: 229-229. DOI: 10.1177/026119298301100407  0.3
1980 Bierkamper GG, Goldberg AM. Release of acetylcholine from the vascular perfused rat phrenic nerve-hemidiaphragm. Brain Research. 202: 234-7. PMID 7427741 DOI: 10.1016/S0006-8993(80)80052-7  0.624
1980 Brookes N, Burt DR, Goldberg AM, Bierkamper GG. The influence of muscle-conditioned medium on cholinergic maturation in spinal cord cell cultures. Brain Research. 186: 474-9. PMID 7357464 DOI: 10.1016/0006-8993(80)90994-4  0.616
1979 Goldberg AM. The effects of inorganic lead on cholinergic transmission. Progress in Brain Research. 49: 465-70. PMID 229519 DOI: 10.1016/S0079-6123(08)64659-2  0.335
1977 Carroll PT, Silbergeld EK, Goldberg AM. Alteration of central cholinergic function by chronic lead acetate exposure. Biochemical Pharmacology. 26: 397-402. PMID 849332 DOI: 10.1016/0006-2952(77)90198-8  0.321
Show low-probability matches.